查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574938

藥物發現市場中的人工智慧，按疾病類型、應用、最終用戶、國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Artificial Intelligence in Drug Discovery Market, By Disease Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年人工智慧藥物發現市場規模為15.9043億美元，2024年至2032年複合年成長率為29.90%。

藥物發現市場中的人工智慧-市場動態

對更快的藥物傳輸和巨量資料進步的需求日益成長，機器學習預計將推動市場需求

COVID-19 大流行凸顯了加速藥物開發的迫切需求。人工智慧快速篩選大量資料集、預測分子交互作用和識別潛在候選藥物的能力是主要驅動力。製藥公司面臨著加快新療法上市時間的壓力，特別是在緊急健康危機或未滿足的醫療需求方面，這使得人工智慧成為一個有吸引力的解決方案。傳統的藥物研發成本極高，估計將新藥推向市場可能花費超過 26 億美元，並且需要 10 至 15 年的時間。人工智慧有可能透過簡化目標識別、先導化合物發現和臨床試驗等流程來顯著降低這些成本。透過自動化任務和減少實驗失敗，人工智慧可以減輕製藥公司的財務負擔。這些好處預計將提振市場需求。

醫療保健和製藥行業從基因組學、蛋白質組學、臨床試驗和現實世界證據（例如電子健康記錄）中產生大量資料。人工智慧在大型資料集上蓬勃發展，支援預測分析並識別隱藏的模式。包括生物和化學資訊在內的高品質醫療資料的可用性不斷增加，增強了人工智慧在藥物發現方面的有效性。深度學習、強化學習、自然語言處理（NLP）等人工智慧技術的快速進步，提高了藥物發現中人工智慧模型的準確性和效率。

藥物發現市場中的人工智慧 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 29.90% 左右的複合年成長率成長

根據疾病類型細分，由於需要預測措施的治療患者的高需求，腫瘤學領域預計將在 2023 年顯示最大的市場佔有率。

根據應用細分，由於快速的研發活動，藥物最佳化和再利用領域是 2023 年領先的應用領域。

根據最終用戶細分，由於製藥公司加大研發投入，研究機構細分市場在 2023 年將成為領先的最終用戶細分市場。

從地區來看，由於人工智慧技術的進步，北美在 2023 年成為領先的收入來源。

藥物發現市場中的人工智慧-細分分析：

全球藥物發現市場中的人工智慧根據疾病類型、應用、最終用戶和地區進行細分。

市場依疾病類型分為五類：腫瘤、心血管疾病、傳染病、代謝疾病等。腫瘤學領域在市場上佔據主導地位。癌症盛行率的不斷上升和有效治療的不斷增加正在推動市場成長。

市場依應用分為三類：藥物最佳化與再利用、臨床前測試等。藥物最佳化和再利用領域主導市場。預計臨床前測試部分將在預測期內大幅成長。

市場依最終用戶分為四大類：研究機構、臨床實驗室等。研究機構領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。製藥公司對藥物發現的投資不斷增加刺激了市場需求。

藥物發現市場中的人工智慧 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美目前是藥物發現領域人工智慧的最大市場，主要受到不斷成長的美國市場的推動。北美擁有強大的研發基礎設施，擁有領先的學術機構和研究組織，並為人工智慧和藥物發現計畫提供了大量資金。歐洲是人工智慧在藥物發現領域的第二大市場。由於強大的醫療基礎設施以及製藥公司和人工智慧公司之間的積極合作，該地區正在迅速被採用。

藥物發現市場中的人工智慧-競爭格局：

藥物發現市場中的人工智慧（AI）競爭激烈且充滿活力，從老牌製藥巨頭到人工智慧驅動的新創公司，許多公司都在積極投資人工智慧技術。公司透過開發獨特的人工智慧模型來競爭，這些模型提供卓越的預測準確性、分子設計效率以及與現有製藥研發系統的整合能力。該公司正在將人工智慧應用從藥物發現擴展到臨床試驗，利用人工智慧來最佳化患者招募、預測結果並減少試驗持續時間和成本。

2023 年，羅氏和 Exscientia 達成合作，利用人工智慧識別新藥物標靶。

2022 年，賽諾菲投資超過 1 億美元與人工智慧公司 Owkin 合作，利用其人工智慧平台進行腫瘤學研究。

2023年，Insilico Medicine獲得2.55億美元融資，用於擴大其人工智慧藥物發現平台。

目錄

第 1 章：藥物發現市場中的人工智慧概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按疾病類型分類的藥物發現市場片段中的人工智慧
    • 人工智慧在藥物發現市場的應用片段
    • 最終用戶在藥物發現市場中的人工智慧片段
    • 人工智慧在藥物發現市場片段（按國家/地區）
    • 按地區分類的藥物發現市場片段中的人工智慧
  • 競爭洞察

第 3 章：藥物發現中的人工智慧主要市場趨勢

  • 人工智慧在藥物發現市場的驅動力
    • 市場促進因素的影響分析
  • 人工智慧對藥物發現市場的限制
    • 市場限制影響分析
  • 藥物發現市場機會中的人工智慧
  • 人工智慧在藥物發現市場的未來趨勢

第 4 章：藥物發現產業研究中的人工智慧

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：藥物發現市場中的人工智慧：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：藥物發現市場格局中的人工智慧

  • 人工智慧在藥物發現市場佔有率分析，2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：藥物發現市場中的人工智慧 - 按疾病類型

  • 概述
    • 按疾病類型分類的細分市場佔有率分析
    • 腫瘤學
    • 心血管疾病
    • 傳染病
    • 代謝性疾病
    • 其他

第 8 章：藥物發現市場中的人工智慧 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 藥物最佳化和再利用
    • 臨床前測試
    • 其他

第 9 章：藥物發現市場中的人工智慧 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 研究所
    • 臨床實驗室
    • 其他

第 10 章：藥物發現市場中的人工智慧 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 藥物發現中的人工智慧北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按疾病類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 藥物發現中的人工智慧歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按疾病類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 藥物發現中的人工智慧亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按疾病類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 藥物發現中的人工智慧拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按疾病類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 藥物發現中的人工智慧中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疾病類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：關鍵供應商分析 - 藥物發現產業中的人工智慧

  • 競爭儀表板
  • 公司簡介
    • Insilico Medicine
    • Atomwise
    • Exscientia
    • BenevolentAI
    • Schrodinger
    • XtalPi
    • Recursion Pharmaceuticals
    • Cyclica
    • Valo Health
    • IBM Watson Health
    • Deep Genomics
    • Bayer AG
    • Roche
    • Pfizer
    • Sanofi
    • AstraZeneca
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3937

REPORT HIGHLIGHT

Artificial Intelligence in Drug Discovery Market size was valued at USD 1,590.43 Million in 2023, expanding at a CAGR of 29.90% from 2024 to 2032.

Artificial Intelligence (AI) in drug discovery is the application of machine learning (ML), deep learning, and other AI techniques to accelerate and improve the process of discovering new drugs. Traditionally, drug discovery is a lengthy, costly, and labor-intensive process that can take more than a decade to bring a new drug to market. AI seeks to enhance various stages of this process by providing faster insights, automating tasks, and reducing costs.

Artificial Intelligence in Drug Discovery Market- Market Dynamics

Growing need for faster drug delivery and advancement in big data, machine learning is expected to propel market demand

The COVID-19 pandemic highlighted the urgent need for faster drug development. AI's ability to quickly sift through vast datasets, predict molecule interactions, and identify potential drug candidates is a major driver. Pharmaceutical companies are under pressure to accelerate time-to-market for new therapies, especially for urgent health crises or unmet medical needs, making AI an attractive solution. Traditional drug discovery is extremely costly, with estimates that bringing a new drug to market can cost over $2.6 billion and take 10-15 years. AI offers the potential to significantly reduce these costs by streamlining processes such as target identification, lead discovery, and clinical trials. By automating tasks and reducing experimental failures, AI can lower the financial burden on pharmaceutical companies. These benefits are expected to bolster the market demand.

The healthcare and pharmaceutical industries generate massive amounts of data from genomics, proteomics, clinical trials, and real-world evidence (e.g., electronic health records). AI thrives on large datasets, enabling predictive analytics and identifying hidden patterns. The growing availability of high-quality healthcare data, including biological and chemical information, fuels AI's effectiveness in drug discovery. Rapid progress in AI techniques such as deep learning, reinforcement learning, and natural language processing (NLP) has improved the accuracy and efficiency of AI models used in drug discovery.

Artificial Intelligence in Drug Discovery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 29.90% over the forecast period (2024-2032)

Based on Disease Type segmentation, the oncology segment was predicted to show maximum market share in the year 2023, owing to high demand from therapeutic patients requiring predictive measures.

Based on Application segmentation, drug optimization & repurposing segment was the leading Application segment in 2023, due to the rapid R&D activities.

Based on End User segmentation, research institutes segment was the leading End User segment in 2023, due to increasing investment by pharma companies in R&D.

On the basis of region, North America was the leading revenue generator in 2023, due to the advancement in AI technologies.

Artificial Intelligence in Drug Discovery Market- Segmentation Analysis:

The Global Artificial Intelligence in Drug Discovery Market is segmented on the basis of Disease Type, Application, End User, and Region.

The market is divided into five categories based on Disease Type: oncology, cardiovascular diseases, infectious diseases, metabolic diseases, and others. The oncology segment dominates the market. The increasing prevalence of cancer and effective treatment available is boosting market growth.

The market is divided into three categories based on Application: drug optimization & repurposing, preclinical testing, and others. The drug optimization & repurposing segment dominates the market. The preclinical testing segment is expected to grow at significant rate over the forecast period.

The market is divided into four categories based on End User: research institutes, clinical laboratories, and others. The research institutes segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising number of investments by pharma companies in drug discoveries is spurring market demand.

Artificial Intelligence in Drug Discovery Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is currently the largest market for AI in drug discovery, primarily driven by the growing United States market. North America has a strong R&D infrastructure with leading academic institutions and research organizations, along with significant funding for AI and drug discovery projects. Europe is the second-largest market for AI in drug discovery. The region is witnessing rapid adoption due to robust healthcare infrastructure and active collaboration between pharmaceutical companies and AI firms.

Artificial Intelligence in Drug Discovery Market- Competitive Landscape:

The Artificial Intelligence (AI) in the Drug Discovery market is highly competitive and dynamic, with numerous companies ranging from established pharmaceutical giants to AI-driven startups actively investing in AI technologies. Companies are competing by developing unique AI models that offer superior prediction accuracy, efficiency in molecule design, and integration capabilities with existing pharma R&D systems. Companies are extending AI applications beyond drug discovery into clinical trials, using AI to optimize patient recruitment, predict outcomes, and reduce trial duration and costs.

In 2023, Roche and Exscientia have formed a collaboration to leverage AI in the identification of novel drug targets.

In 2022, Sanofi invested over $100 million in a partnership with AI firm Owkin to leverage its AI platform for oncology research.

In 2023, Insilico Medicine received USD 255 million in funding to scale up its AI drug discovery platform.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET KEY PLAYERS

  • Insilico Medicine
  • Atomwise
  • Exscientia
  • BenevolentAI
  • Schrodinger
  • XtalPi
  • Recursion Pharmaceuticals
  • Cyclica
  • Valo Health
  • IBM Watson Health
  • Deep Genomics
  • Bayer AG
  • Roche
  • Pfizer
  • Sanofi
  • AstraZeneca
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Oncology
  • Cardiovascular diseases
  • Infectious diseases
  • Metabolic diseases
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Drug optimization & repurposing
  • Preclinical testing
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Research Institutes
  • Clinical Laboratories
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Artificial Intelligence in Drug Discovery Market Snippet by Disease Type
    • 2.1.2. Artificial Intelligence in Drug Discovery Market Snippet by Application
    • 2.1.3. Artificial Intelligence in Drug Discovery Market Snippet by End User
    • 2.1.4. Artificial Intelligence in Drug Discovery Market Snippet by Country
    • 2.1.5. Artificial Intelligence in Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. Artificial Intelligence in Drug Discovery Key Market Trends

  • 3.1. Artificial Intelligence in Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Drug Discovery Market Opportunities
  • 3.4. Artificial Intelligence in Drug Discovery Market Future Trends

4. Artificial Intelligence in Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Drug Discovery Market Landscape

  • 6.1. Artificial Intelligence in Drug Discovery Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Drug Discovery Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 7.1.2. Oncology
    • 7.1.3. Cardiovascular diseases
    • 7.1.4. Infectious diseases
    • 7.1.5. Metabolic diseases
    • 7.1.6. Others

8. Artificial Intelligence in Drug Discovery Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Drug optimization & repurposing
    • 8.1.3. Preclinical testing
    • 8.1.4. Others

9. Artificial Intelligence in Drug Discovery Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Research Institutes
    • 9.1.3. Clinical Laboratories
    • 9.1.4. Others

10. Artificial Intelligence in Drug Discovery Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Artificial Intelligence in Drug Discovery Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Artificial Intelligence in Drug Discovery Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Artificial Intelligence in Drug Discovery Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Artificial Intelligence in Drug Discovery Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Artificial Intelligence in Drug Discovery Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Artificial Intelligence in Drug Discovery Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Insilico Medicine
    • 11.2.2. Atomwise
    • 11.2.3. Exscientia
    • 11.2.4. BenevolentAI
    • 11.2.5. Schrodinger
    • 11.2.6. XtalPi
    • 11.2.7. Recursion Pharmaceuticals
    • 11.2.8. Cyclica
    • 11.2.9. Valo Health
    • 11.2.10. IBM Watson Health
    • 11.2.11. Deep Genomics
    • 11.2.12. Bayer AG
    • 11.2.13. Roche
    • 11.2.14. Pfizer
    • 11.2.15. Sanofi
    • 11.2.16. AstraZeneca
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us